← All trials
NCT04913649
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 23, 2021
- Primary completion
- Sep 30, 2022
- Completion date
- Dec 31, 2022
- First posted
- Jun 4, 2021
- Last posted
- Sep 29, 2021
- Enrollment
- 310
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- St. Antonius Hospital, NieuwegeinLead sponsor
- PharmacosmosCollaborator
- St. Antonius Hospital, NieuwegeinSponsor investigator
- St. Antonius Hospital, NieuwegeinOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.